STRS Ohio’s Avita Medical RCEL Stock Holding History

STRS Ohio’s Portfolio RCEL Stock Details RCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-47,700	Closed	-$176K	–	2291
2026 Q1	$176K	Hold	47,700	–	–	﹤0.01%	1552
2025 Q4	$165K	Hold	47,700	–	–	﹤0.01%	1611
2025 Q3	$244K	Buy	47,700 +33,400	+234%	+$174K	﹤0.01%	1441
2025 Q2	$75.6K	Hold	14,300	–	–	﹤0.01%	1945
2025 Q1	$116K	Hold	14,300	–	–	﹤0.01%	1638
2024 Q4	$183K	Hold	14,300	–	–	﹤0.01%	1532
2024 Q3	$153K	Hold	14,300	–	–	﹤0.01%	1630
2024 Q2	$113K	Sell	14,300 -17,300	-55%	-$165K	﹤0.01%	1676
2024 Q1	$506K	Sell	31,600 -9,500	-23%	-$154K	﹤0.01%	1254
2023 Q4	$563K	Buy	41,100 +4,200	+11%	+$48.1K	﹤0.01%	1216
2023 Q3	$539K	Buy	36,900 +900	+3%	+$15.2K	﹤0.01%	1217
2023 Q2	$612K	Buy	+36,000	New	+$528K	﹤0.01%	1166
2022 Q2	–	Sell	-5,500	Closed	-$46K	–	2241
2022 Q1	$46K	Hold	5,500	–	–	﹤0.01%	1955
2021 Q4	$65K	Hold	5,500	–	–	﹤0.01%	1966
2021 Q3	$97K	Hold	5,500	–	–	﹤0.01%	1947
2021 Q2	$112K	Buy	+5,500	New	+$108K	﹤0.01%	1951

Other funds holding RCEL

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

STRS Ohio's RCEL Position: Q2 2026 in Review

STRS Ohio sold out of Avita Medical (RCEL) in Q2 2026, closing a stake of 47,700 shares — an estimated $176K sold.

STRS Ohio first reported a position in RCEL in Q2 2021 and held it in 16 quarters. The position peaked at $612K in Q2 2023. 74 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

STRS Ohio reported no remaining Avita Medical position as of Q2 2026 after selling out during the quarter.
STRS Ohio sold 47,700 Avita Medical shares in Q2 2026, an estimated $176K.
STRS Ohio first reported a position in Avita Medical in Q2 2021 and held it in 16 quarters.
STRS Ohio's Avita Medical position peaked at $612K in Q2 2023.
74 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.